Widimský Jiří
Vnitr Lek. 2016 Feb;62(2):107-13.
Angiotensin receptor antagonists (AT(1)-blockers) are considered as one of the major classes of antihypertensive drugs suitable for monotherapy as well as for combination treatment. AT(1)-blockers have comparable antihypertensive efficacy with other major classes of antihypertensive drugs. AT(1)-blockers are considered by current guidelines of Czech society of hypertension altogether with ACE-inhibitors and calcium channel blockers as universal antihypertensive drug class. AT(1)-blockers has the lowest profile of side-effects among all antihypertensive drug classes and thus very high persistence to therapy. Mechanisms of antihypertensive effects of AT(1)-blockers are discussed altogether with the results of large clinical trials and indications in the treatment of hypertension.
血管紧张素受体拮抗剂(AT(1)阻滞剂)被认为是适用于单药治疗以及联合治疗的主要抗高血压药物类别之一。AT(1)阻滞剂与其他主要抗高血压药物类别具有相当的抗高血压疗效。捷克高血压学会的现行指南将AT(1)阻滞剂与ACE抑制剂和钙通道阻滞剂一并视为通用抗高血压药物类别。在所有抗高血压药物类别中,AT(1)阻滞剂的副作用最少,因此对治疗的依从性非常高。本文结合大型临床试验结果和高血压治疗适应证,对AT(1)阻滞剂的降压作用机制进行了讨论。